Correlation Between Kura Oncology and Deciphera Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Deciphera Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Deciphera Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kura Oncology and Deciphera Pharmaceuticals LLC, you can compare the effects of market volatilities on Kura Oncology and Deciphera Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Deciphera Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Deciphera Pharmaceuticals.

Diversification Opportunities for Kura Oncology and Deciphera Pharmaceuticals

0.0

Correlation Coefficient

Kura Oncology  Deciphera Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Kura and Deciphera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Deciphera Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Deciphera Pharmaceuticals and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Deciphera Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Deciphera Pharmaceuticals has no effect on the direction of Kura Oncology i.e., Kura Oncology and Deciphera Pharmaceuticals go up and down completely randomly.

Pair Corralation between Kura Oncology and Deciphera Pharmaceuticals

If you would invest (100.00) in Deciphera Pharmaceuticals LLC on November 29, 2024 and sell it today you would earn a total of  100.00  from holding Deciphera Pharmaceuticals LLC or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Kura Oncology  vs.  Deciphera Pharmaceuticals LLC

Kura Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Deciphera Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Deciphera Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Deciphera Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Kura Oncology and Deciphera Pharmaceuticals

The main advantage of trading using opposite Kura Oncology and Deciphera Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Deciphera Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deciphera Pharmaceuticals will offset losses from the drop in Deciphera Pharmaceuticals' long position.

The idea behind Kura Oncology and Deciphera Pharmaceuticals LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.